Nexalin Technology (NXL) Operating Expenses (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Operating Expenses of $2.1 million for Q1 2026, up 4.63% year-over-year from $2.0 million in Q1 2025, and down 16.81% quarter-over-quarter from $2.6 million in Q4 2025.
Nexalin Technology (NXL) Operating Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Operating Expenses history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 4.63% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.7 million (down 0.65% YoY), while the FY2025 annual figure was $8.6 million, up 9.44% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.1 million, down from $2.6 million in the prior quarter.
- The five-year high for Operating Expenses was $2.9 million in Q4 2024, with the low at $651219.0 in Q3 2022.
- The 5-year median for Operating Expenses is $1.6 million (2023), against an average of $1.6 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses slumped 64.65% in 2022, then surged 274.02% in 2023.
- Nexalin Technology's Operating Expenses stood at $751174.0 in 2022, then jumped by 118.3% to $1.6 million in 2023, then surged by 76.55% to $2.9 million in 2024, then slipped by 11.43% to $2.6 million in 2025, then decreased by 16.81% to $2.1 million in 2026.
- Business Quant data shows NXL's Operating Expenses at $2.1 million in Q1 2026, $2.6 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 903,026.00 |
| Mar 31, 2023 | 802,876.00 |
| Dec 31, 2022 | 751,174.00 |
| Sep 30, 2022 | 651,219.00 |
| Jun 30, 2022 | 736,359.00 |
| Mar 31, 2022 | 652,424.00 |
| Dec 31, 2021 | 602,494.00 |
| Sep 30, 2021 | 1.84 Mn |